Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib

Published:2018-10-24 Issue:6 Volume:32 Page:2061-2068
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Kovac Rachel L.¹^ORCID,Ballash Gregory²,Fenger Joelle¹,London Cheryl³⁴,Warry Emma¹

Affiliation:

1. Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University; Columbus Ohio

2. Department of Veterinary Preventative Medicine, College of Veterinary Medicine, The Ohio State University; Columbus Ohio

3. Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University; Columbus Ohio

4. Department of Veterinary Biosciences, College of Veterinary Medicine, Tufts University; New Grafton Massachusetts

Funder

Ohio State University

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvim.15326/fullpdf

Reference34 articles.

1. c-KIT mutation and localization status as response predictors in mast cell tumors in dogs treated with prednisone and Toceranib or vinblastine;Weishaar;J Vet Intern Med,2018

2. Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose;Bernabe;BMC Vet Res,2013

3. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision;London;Clin Cancer Res,2009

4. Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1;Vet Comp Oncol,2016

5. Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with Sunitinib;Keizman;Oncologist,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Cytokeratin 18 and fecal Alpha‐1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy;Veterinary Medicine and Science;2020-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3